Medifast, Inc.MEDNYSE
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank71
3Y CAGR-20.5%
5Y CAGR+3.5%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-20.5%/yr
Annual compound
5Y CAGR
+3.5%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20250.08+9.9%
20240.08-29.8%
20230.11-35.0%
20220.17+4.5%
20210.16+126.4%
20200.07-45.3%
20190.13-
20180.00-
20170.00-100.0%
20160.01-